BioSpace News Archive

BioCapital

(ASCO2020) Ascentage Pharma Presents Latest Clinical Data of Apoptosis Targeting Drug Candidates, Showing Promising Clinical Effects with Combination Therapies

Ascentage Pharma announced that the company presented four posters of the latest clinical data on three of its drug candidates, including the MDM2-p53 inhibitor APG-115, novel Bcl-2/Bcl-xL dual inhibitor palcitoclax or APG-1252, and IAP inhibitor APG-1387, at the 2020 American Society of Clinical Oncology Annual Meeting.

May 31, 2020
·
13 min read
Drug Development

BioMarin Provides Highlights of 4 Years of Clinical Data from Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A

BioMarin Pharmaceutical Inc. announced an update to its previously reported results of an open-label Phase 1/2 study of valoctocogene roxaparvovec, an investigational gene therapy treatment for adults with severe hemophilia A.

May 31, 2020
·
9 min read
Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type)

Innovent Biologics, Inc. announced the two-year follow-up results of TYVYT® ORIENT-4 study in relapsed or refractory Extranodal NK/T-cell lymphoma at the 56th Annual Meeting of the American Society of Clinical Oncology .

May 31, 2020
·
4 min read
Drug Development

Immutep Announces Improving Data from the Phase II TACTI-002 Study

Immutep Limited announces new interim data from its ongoing Phase II TACTI-002 study.

May 31, 2020
·
4 min read